MedTrace Logo

Biomarkers And Neurological Outcome in Neonates 2

NCT04714775 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-01-20

No results posted yet for this study

Summary

Follow-up of participants of BANON1 study at age of at least 2 years. BANON1 (ClinicalTrials.gov ID: NCT03357250): Validation of biomarkers based on 24 months neuro-developmental outcome data in a human population for their ability to diagnose the severity of neonatal asphyxia. These biomarkers linked to asphyxia have been identified in animal studies and a preliminary human study.

Conditions

  • Asphyxia Neonatorum

Sponsors & Collaborators

  • University Hospital Tuebingen

    collaborator OTHER

  • InfanDx AG

    lead INDUSTRY

Principal Investigators

  • Ron Meyer · InfanDx AG

Eligibility

Min Age
22 Months
Max Age
48 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-05
Primary Completion
2021-06-30
Completion
2021-12-31

Countries

  • Germany
  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04714775 on ClinicalTrials.gov